MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

Search

Axsome Therapeutics Inc

Închisă

SectorSănătate

97.16 -1.27

Rezumat

Modificarea prețului

24h

Curent

Minim

95.98

Maxim

102.23

Indicatori cheie

By Trading Economics

Venit

-10M

-75M

Vânzări

14M

119M

EPS

-1.54

Marjă de profit

-63.075

Angajați

683

EBITDA

-10M

-71M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+78.55% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-1.4B

4.8B

Deschiderea anterioară

98.43

Închiderea anterioară

97.16

Sentimentul știrilor

By Acuity

20%

80%

33 / 385 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

Axsome Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 apr. 2025, 22:42 UTC

Principalele dinamici ale pieței

Peabody Energy Shares Climb on Trump Executive Orders Boosting Coal Industry

8 apr. 2025, 22:35 UTC

Câștiguri
Principalele dinamici ale pieței

Cal-Maine Foods Shares Fall As Justice Dept Probes Egg Prices

8 apr. 2025, 21:30 UTC

Câștiguri

Cal-Maine Foods Cooperating With Justice Dept Probe Into Egg Price Increases -- Update

8 apr. 2025, 21:21 UTC

Câștiguri

Cal-Maine Foods Cooperating With Justice Dept Probe into Egg Price Increases

9 apr. 2025, 00:00 UTC

Top știri

Trump's Tariffs Put Fed Chair Powell in a 'No-Win Situation' -- WSJ

8 apr. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 apr. 2025, 23:45 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

8 apr. 2025, 23:43 UTC

Market Talk

Lithium Oversupply Weighs on Price Outlook -- Market Talk

8 apr. 2025, 23:43 UTC

Achiziții, Fuziuni, Preluări

Woolworths' Rivals Have Other Options to Source Ready Meals, ACCC Says

8 apr. 2025, 23:42 UTC

Market Talk

Gold Falls on Possible Unwinding of Long Positions to Raise Cash -- Market Talk

8 apr. 2025, 23:42 UTC

Achiziții, Fuziuni, Preluări

Beak & Johnston Makes Ready Meals, Pastries for Wholesale, Retail

8 apr. 2025, 23:41 UTC

Achiziții, Fuziuni, Preluări

Woolworths' Acquisition Unlikely to Have Substantial Anti-Competitive Effect, ACCC Says

8 apr. 2025, 23:40 UTC

Achiziții, Fuziuni, Preluări

Australian Competition and Consumer Commission: Will Not Oppose Transaction

8 apr. 2025, 23:39 UTC

Achiziții, Fuziuni, Preluări

Australian Competition Regulator to Allow Woolworths' Acquisition of Beak & Johnston

8 apr. 2025, 23:21 UTC

Achiziții, Fuziuni, Preluări

U.S. Steel: $75 per Shr That the Ancora 'Plan' Proposes Is Really an Unrealistic, Distant Future Value Pipedream Rooted Firmly in Fiction >X

8 apr. 2025, 23:21 UTC

Achiziții, Fuziuni, Preluări

U.S. Steel: Stockholders Should Be Very Skeptical of Ancora's 'Plan' or That Their Nominees Could or Would Vigorously Fight for the Nippon Steel Deal >X

8 apr. 2025, 21:26 UTC

Top știri

When Coffee Mate Made a 'White Lotus' Piña Colada Creamer, It Had No Idea How the Season Would End -- WSJ

8 apr. 2025, 21:26 UTC

Câștiguri

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

8 apr. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Peabody Energy: Remains in Conversation With Anglo Amer to Better Understand Impacts of Event, Preserving All Rights and Protections Under Purchase Agreements >BTU

8 apr. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Peabody Energy: Following Ignition Event Last Week at Anglo Amer's Moranbah North Mine, Reviewing Options Related to Acquisition of Steelmaking Coal Assets From Anglo Amer >BTU

8 apr. 2025, 21:06 UTC

Top știri

Stocks Are in Turmoil, but Treasury Yields Are Stubbornly High -- Update

8 apr. 2025, 20:50 UTC

Top știri

Harley-Davidson Seeks New CEO, Facing Sales Slump and Tariffs -- 3rd Update

8 apr. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8 apr. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 apr. 2025, 20:40 UTC

Câștiguri

BYD Stock Soars. It's Catching Up to Tesla in Yet Another Way. -- Barrons.com

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: Will Release 1Q Results on May 6 After Markets Close >SSL.T

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: During Three Mos Ended March 31, Realized Record Preliminary Revenue of $50.1M (20,316 Attributable Gold Equivalent Ounces and $42.8M in Rev for the Comparable Period in 2024) >SSL.T

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: Record Preliminary Total Sales, Royalties, Income From Other Interests of $54.1M for Three Mos Ended March 31 ($42.8M in Total Sales, Royalties, Income From Other Interests for Comparable Period in 2024) >SSL.T

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: During Three Mos Ended March 31, Sold Approximately 18,500 Attributable Gold Equivalent Ounces >SSL.T

8 apr. 2025, 20:14 UTC

Top știri

U.S. Stocks Retreat as Optimism Over Trade Talks Fades -- WSJ

Comparație

Modificare preț

Axsome Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

78.55% sus

Prognoză pe 12 luni

Medie 175.87 USD  78.55%

Maxim 216 USD

Minim 133 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAxsome Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

18 ratings

18

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

92.5278 / 98.7997Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

33 / 385 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Axsome Therapeutics Inc

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.